Press releases | WebDisclosure

Basculer en Français

11295	Companies
251024	Keywords
179962	Articles
136885	Press releases

Home
Press releases

PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Carvolix submits 510(k) for TAVIPILOT Robot, advancing towards US commercial launch of its integrated TAVIPILOT platform, supported by clinical studies and market expansion opportunities

510(k) Submission Clinical Studies Carvolix TAVIPILOT Robot US Market Launch
PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

Carvolix dépose le dossier 510(k) pour le robot TAVIPILOT et progresse vers le lancement commercial de sa plateforme TAVIPILOT aux États-Unis.
Carvolix dépose le dossier 510(k) pour le robot TAVIPILOT et avance vers le lancement commercial de sa plateforme aux États-Unis, suite à une étude réussie et à l'évolution favorable du marché américain du TAVI

FDA Carvolix Robotique Médicale TAVIPILOT Dossier 510(k)
REGULATED PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Imerys reports number of outstanding shares and voting rights as of 31 August 2026, in accordance with French regulations. Learn about the leading mineral-based solutions provider

Voting Rights French Regulations Outstanding Shares Imerys Mineral-Based Solutions
REGULATED PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026
Imerys, leader mondial spécialités minérales pour l’industrie, chiffre d’affaires 3,4 milliards € en 2025, coté sur Euronext Paris (code NK.PA)

Euronext Paris Industrie Imerys Spécialités Minérales Leader Mondial
PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

COMMUNIQUE DE PRESSE RELATIF A UNE NOTIFICATION DE TRANSPARENCE
Communiqué de presse relatif à une notification de transparence concernant Econocom et le franchissement du seuil des 75% de droits de votes par M. Jean-Louis Bouchard, Econocom International BV et Econocom Group SE

Econocom Notification De Transparence Communiqué Franchissement Seuil % Droits De Votes
PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

PRESS RELEASE ON TRANSPARENCY NOTIFICATION
Econocom's transparency notification reveals M. Jean-Louis Bouchard, Econocom International BV, and Econocom Group SE crossed 75% voting rights threshold due to recent acquisition

Acquisition Voting Rights Transparency Notification Econocom Significant Shareholdings
PRESS RELEASE

published on 09/22/2026 at 17:45, 1 month 16 days ago

Mise à disposition à des comptes semestriels 2026
Kumulus Vape publie ses comptes semestriels sociaux et consolidés au 30 juin 2026. Le spécialiste de la vape offre une alternative au tabac fumé depuis 2012

Euronext Growth Kumulus Vape Cigarette Électronique Comptes Semestriels VAPE
PRESS RELEASE

published on 09/22/2026 at 17:43, 1 month 16 days ago

West Red Lake Gold Reports 176.04 g/t Au over 5.3m, 128.32 g/t Au over 4.5m and 35.72 g/t Au over 13.35m from Austin 955 and 904 Complexes
Vancouver, British Columbia, September 22nd, 2026, FinanceWire
PRESS RELEASE

published on 09/22/2026 at 17:40, 1 month 16 days ago

VALBIOTIS SA: Valbiotis annonce les résultats positifs de l'étude clinique Cardio-Liver - Lancement commercial de ValbiotisPRO® Foie dès le 23 septembre
Valbiotis annonce les résultats positifs de l'étude clinique Cardio-Liver, lancement commercial de ValbiotisPRO® Foie le 23 septembre. Nouvelle solution pour la santé hépatique

Valbiotis Cardio-Liver Steadrive® ValbiotisPRO® Foie Santé Hépatique
PRESS RELEASE

published on 09/22/2026 at 17:40, 1 month 16 days ago

VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23
Valbiotis announces positive results from Cardio-Liver study and commercial launch of ValbiotisPRO® Foie on September 23. Study confirms efficacy of Steadrive® on liver fat reduction

Valbiotis Clinical Trial Steadrive® Cardio-Liver Study ValbiotisPRO® Foie

Accesswire

Published on 11/06/2026 at 22:15, 2 days 12 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 21 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 22 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 22 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 3 days ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 10:13, 22 minutes ago

POS-Transaction in Own Shares
Published on 11/09/2026 at 10:05, 29 minutes ago

Reactive Technologies Appoints Former Hitachi Energy CEO Claudio Facchin as Board Chairman
Published on 11/09/2026 at 10:00, 35 minutes ago

Deutsche Beteiligungs AG: Green Datahub data centres successfully sold
Published on 11/09/2026 at 09:30, 1 hour 5 minutes ago

Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 1 hour 34 minutes ago

Cantourage further develops Telecan and strengthens digital access to medical care

Les Echos

Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 3 hours 35 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 15 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026

View all LES ECHOS COMFI WIRE